Anti-inflammatory and antiproliterative activities of trifolirhizin, a flavonoid from Sophora flavescens roots

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 11, 2009, Pages 4580-4585

  Zhou, Huiping ^a   Lutterodt, Herman ^b   Cheng, Zhihong ^b   Yu, Liangli ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Anti inflammation; COX 2; IL 6; Sophora flavescens; TNF ; Trifolirhizin

Indexed keywords

SOPHORA; SOPHORA FLAVESCENS;

ANTIINFLAMMATORY AGENT; CYTOKINE; FLAVONOID; FUSED HETEROCYCLIC RINGS; GLUCOSIDE; TRIFOLIRHIZIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; MOUSE; PLANT ROOT; SOPHORA; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; FLAVONOIDS; GENE EXPRESSION; GLUCOSIDES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MACROPHAGES; MICE; PLANT ROOTS; SOPHORA;

EID: 67149144583     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf900340b     Document Type: Article

References (25)

1. Macarthur, M.; Hold, G. L.; El-Omar, E. M. Inflammation and cancer 11. Role of chronic inflammation and cytokines gen polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G515-G520.
2. Beutler, B.; Cerami, A. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 1989, 7, 625-655.
3. Pecoits-Filho, R.; Lindholm, B.; Axelsson, J.; Stenvinkel, P. Update on interleukin-6 and its role in chronic renal failure. Nephrol., Dial., Transplant. 2003, 18, 1042-1045.
4. Crofford, L.-J.; Lipsky, P.-E.; Brooks, P.; Abramson, S.-B.; Simon, L. S.; van de Putte, L. B. A. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum. 2000, 43, 4-13.
5. Yagi, A.; Fukunaga, M.; Okuzako, N.; Mifuchi, I.; Kawamoto, F. Antifungal substances from Sophora flavescens. ShoyakugakuZasshi 1989, 43, 343-347.
6. Kuroyanagi, M.; Arakawa, T.; Hirayama, Y.; Hayashi, T. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J. Nat. Prod. 1999, 62, 1595-1599.
7. Kim, D. W.; Chi, Y. S.; Son, K. H.; Chang, H. W.; Kim, J. S.; Kang, S. S.; Kim, H. P. Effects of sophoraflavanone G, a preny-lated flavonoid from Sophora flavescenes, on cyclooxygenase-2 and in vitro inflammatory response. Arch. Pharm. Res. 2002, 25, 329-335.
8. Hwang, J.-S.; Lee, S. A.; Hong, S. S.; Lee, K. S.; Lee, M. K.; Hwang, B. Y.; Ro, J. S. Monoamine oxidase inhibitory components from the roots, of Sophora flavescens. Arch. Pharm Res. 2005, 28, 190-194.
9. Jung, H. J.; Kang, S. S.; Hyun, S. K.; Choi, J.-S. In vitro free radical and ONOO-scavengers from Sophora flavescens. Arch. Pharm. Res. 2005, 28, 534-540.
10. Ko, W. G.; Kang, T. H.; Kim, N. Y.; Lee, S. J.; Kim, Y. C.; Ko, G. I.; Ryu, S. Y.; Lee, B. H. Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol. In Vitro 2000, 14, 429-433.
11. Zhou, H.; Jarujaron, S.; Gurley, E. C.; Chen, L.; Ding, H.; Studer, E.; Pandak, W. M. Jr; Hu, W.; Zou, T.; Wang, J.; Hylemon, P. B. HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR. Atherosclerosis 2007, 195, el34-el43.
12. Zhou, H.; Pandak, W. M. Jr; Lyall, V.; Natarajan, R.; Hylemon, P. B. HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease. Mol. Pharmacol. 2005, 68, 690-700.
13. Cheng, Z.; Morre, J.; Yu, L. High-throughput relative DPPH radical scavenging capacity assay. J. Agric. Food Chem. 2006, 54, 7429-7436.
14. Aratanechemuge, Y.; Hibasami, H.; Katsuzaki, H.; Imai, K.; Komiya, T. Induction of apoptosis by maackiain and trifolirhizin (maackiain glycoside) isolated from sanzukon (Sophora suhprostrate Chenet T. Chen) in human promyelotic leukemia HL-60 cells. Oncol. Rsp. 2004, 12, 1183-1188.
15. Hietala, P. K. A countercurrent distribution method for separation of chemical compounds. Ann. Acad. Sci. 1960, 100 (Fennicae, Series A II Chemica), 54-62.
16. 1 (ginseng), and parthenolide (feverfew). Food Chem. Toxicol. 2003, 41, 1381-1390.
17. Xagorari, A.; Papapetropoulous, A.; Mauromatics, A.; Economou, M.; Fotsis, T.; Roussos, C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther. 2001, 296, 181-187.
18. Aggarwal, B. B.; Shishodia, S.; Sandur, S. K.; Pandey, M. K.; Sethi, G. Inflammation and cancer: How hot is the link? Biochem. Pharmacol 2006, 72, 1605-1621.
19. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lgncet 2001, 357, 539-545.
20. Yuan, Z.-P.; Chen, L.-J.; Fan, L.-Y.; Tang, M.-H.; Yang, G.-L.; Yang, H.-S.; Du, X.-B.; Wang, G.-Q.; Yao, W.-X.; Zhao", Q.-M.; Wang, R.; Diao, P.; Zhang, W.; Wu, H.-B.; Zhao, X.; Wei, Y.-Q. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 2006, 12, 3193-3199.
21. Nair, H. K.; Rao, K. V. K.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Schwartz, S. A. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin. Diagn. Lab. Immunol. 2004, 11, 63-69.
22. Jones, D. J. L.; Lamb, J. H.; Verschoyle, R. D.; Howells, L. M.; Butterworth, M.; Lim, C. K.; Ferry, D.; Fanner, P. B.; Gescher, A. J. Characterization of metabolites of the putative cancer chemopre-ventive agent quercetin and their effect on cyclo-oxygenase activity. Br. J. Cancer 2004, 91, 1213-1219.
23. Fang, J.; Zhou, Q.; Shi, X.; Jiang, B. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcino-gnesis 2006, 28, 713-723.
24. Winrow, V. R.; Winyard, P. G.; Morris, C. J.; Blake, D. R. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br. Med. Bull. 1993, 49, 506-522.
25. Schreck, R.; Rieber, P.; Baeuerle, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 1991, 10, 2247-2258.